Vaxcyte (PCVX) Financials

$61.17

$-0.41 (-0.67%)

As on 03-Sep-2026 16:05EDT

Market cap

$8,904 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

3.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.87	--	15.85	75.00	9.20	1.80
Gross Profit	-0.87	--	-15.85	-75.00	-9.20	-1.80
Operating Expenses	1,164.43	923.68	569.55	468.04	232.26	103.67
Operating Profit (EBIT)	-1,165.29	-923.68	-569.55	-468.04	-232.26	-103.67
Other Income	--	--	--	--	--	3.59
Profit before Tax	-1,064.26	-766.63	-463.93	-402.27	-223.49	-100.08
Provision for Tax	--	--	--	-402.27	16.16	0.01
Profit after Tax (Net Income)	-1,064.26	-766.63	-463.93	-402.27	-223.49	-100.08
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-223.49	-100.08

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	2,757.94	2,685.51	3,305.82	1,240.47	953.61	284.02
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	108.94	154.70	65.32	22.11	12.04	11.60
Current Liabilities	271.28	205.75	140.18	145.34	40.53	28.72
Total Liabilities	3,409.43	3,045.97	3,511.32	1,407.92	1,006.18	324.34

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	1,585.49	1,418.60	1,723.33	311.96	63.62	67.99
Current Assets	1,552.67	1,627.36	1,787.99	1,095.95	942.56	256.35
Total Assets	3,409.43	3,045.97	3,511.32	1,407.92	1,006.18	324.34
Total Debt*	115.45	228.84	71.11	29.22	17.94	16.78
Net Current Assets	1,281.39	1,421.61	1,647.81	950.62	902.03	227.63

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-655.58	-452.63	-296.79	-170.60	-121.39
Cash Flow from Investing Activities	--	437.35	-2,005.67	-773.31	74.59	-212.31
Cash from Financing Activities	--	2.01	2,448.51	639.81	861.55	17.80
Net Cash Inflow / Outflow	--	--	--	--	--	-315.91

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-7.64	-5.63	-3.78	-3.85	-2.96	-1.83
Cash EPS ($)	--	-5.45	-3.65	-3.75	-2.84	-1.77
Adjusted Book Value ($)	--	19.73	26.91	11.88	12.62	5.19
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-4.82	-3.68	-2.84	-2.26	-2.22
Free Cash Flow per Share ($)	--	-4.92	-3.87	-3.49	-2.34	-2.34

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-24.37	-19.97	-35.90	-35.13	-30.95
ROE (%)	-39.10	-25.59	-20.41	-36.67	-36.11	-31.78
ROA (%)	-30.99	-23.38	-18.86	-33.33	-33.59	-27.91
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	-2,785.33
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-113.26	-65.25	-15.33	-80.00	-123.33	-12.17
Net Profit Growth (%)	-94.39	-65.25	-15.33	-80.00	-123.31	-12.17
EPS Growth (%)	-81.42	-0.49	0.02	-0.30	-0.62	-0.04
Book Value Growth (%)	-15.46	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-8.19	-21.68	-16.30	-16.21	-13.01
Price / Book Value	3.30	2.34	3.04	5.29	3.80	4.58
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-14.43	-6.67	-18.70	-14.04	-12.66	-11.11
Close Price ($)	58.13	46.14	81.86	62.80	47.95	23.79
High Price ($)	64.79	93.77	121.06	64.04	48.19	30.88
Low Price ($)	29.08	27.66	53.83	34.11	16.78	15.51
Market Cap ($ Cr)	8,903.76	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.09	0.02	0.02	0.02	0.06
Short term debt to equity ratio	0.00	0.00	0.00	0.01	0.01	0.02
Current Ratio	5.72	7.91	12.75	7.54	23.26	8.93
Quick Ratio	5.72	--	--	7.58	23.28	8.97
Interest Coverage	--	--	--	--	-111,741.50	-14,295.71

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	-141.97	-17.43	-43.69	-152.19
Payable days	--	--	726.57	59.37	328.73	3,707.59
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.